Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?

BACKGROUND: Pulmonary infections caused by non-tuberculous mycobacteria (NTM) are hard to treat and have low cure rates despite intensive multidrug therapy. OBJECTIVES: To assess the feasibility of tedizolid, a new oxazolidinone, for the treatment of Mycobacterium avium and Mycobacterium abscessus....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Antimicrob Chemother
Hlavní autoři: Ruth, Mike Marvin, Koeken, Valerie A C M, Pennings, Lian J, Svensson, Elin M, Wertheim, Heiman F L, Hoefsloot, Wouter, van Ingen, Jakko
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021090/
https://ncbi.nlm.nih.gov/pubmed/31886864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz511
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky